Harte Hanks Files 8-K: Director/Officer Changes & More

Ticker: HHS · Form: 8-K · Filed: Jan 28, 2025 · CIK: 45919

Sentiment: neutral

Topics: leadership-change, governance, filing

Related Tickers: HHS

TL;DR

Harte Hanks 8-K dropped: new directors, officers, and comp plans. Big shakeup!

AI Summary

Harte Hanks, Inc. filed an 8-K on January 28, 2025, reporting events as of January 23, 2025. The filing covers the departure and election of directors, appointment of officers, compensatory arrangements, Regulation FD disclosures, and other events, including financial statements and exhibits.

Why It Matters

This filing indicates significant changes in the company's leadership and governance structure, which could impact strategic direction and investor confidence.

Risk Assessment

Risk Level: medium — Changes in directors and officers, along with compensatory arrangements, can signal strategic shifts or internal adjustments that may carry inherent risks.

Key Players & Entities

FAQ

What specific changes were made regarding directors and officers?

The filing indicates the departure of directors, election of new directors, and appointment of certain officers.

Are there any details on compensatory arrangements for officers?

Yes, the filing explicitly mentions 'Compensatory Arrangements of Certain Officers' as an item of disclosure.

What is the significance of the 'Regulation FD Disclosure' item?

This indicates that the company is making public disclosures to prevent selective disclosure of material non-public information.

What other types of events are reported in this 8-K?

Besides director and officer changes, the filing also covers 'Other Events' and 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on January 23, 2025.

Filing Stats: 1,573 words · 6 min read · ~5 pages · Grade level 11.3 · Accepted 2025-01-28 16:01:59

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. A copy of the press release announcing the foregoing events is furnished herewith as Exhibit 99.1 and is incorporated in this Item 7.01 by reference.

01 Other Events

Item 8.01 Other Events. N/A Cautionary Note Regarding Forward-Looking Statements This report contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Generally, words such as "anticipate," "estimate," "expect," "project," "intend," "believe," "plan," "target," "forecast" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements concern management's expectations, strategic objectives, business prospects, anticipated economic performance and financial condition and other similar matters. Forward-looking statements are inherently uncertain and subject to a variety of assumptions, risks and uncertainties that could cause actual results to differ materially from those anticipated or expected by the management of the Company. These statements are not guarantees of future performance and actual events or results may differ significantly from these statements. Actual events or results are subject to significant known and unknown risks, uncertainties and other important factors, many of which are beyond the Company's control and are described in the Company's filings with the United States Securities and Exchange Commission (the "SEC"). It should be understood that it is not possible to predict or identify all such factors. Given these risk factors, investors and analysts should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of the document in which they are made. The Company disclaims any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which the forward-looking statement is based, except as required by law. It is advisable, however, to consult any further disclosures the Company makes on related subjects in its filings with the SEC, including Annual Re

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No Description 10.1 Employment Agreement between the Company and David Fisher, effective as of January 27th, 2025. 99.1 Press Release of the Company dated January 28 , 202 5 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HARTE HANKS, INC. Date: January 28, 2025 By: /s/ Robert Wyman Robert Wyman General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing